EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Sept. 6, 2006--Dutton Associates updates its coverage of Clearant Inc. (OTCBB:CLRI) for announcement of formation of the FDA tissue safety task force,...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Aug. 14, 2006--Dutton Associates updates its coverage of Clearant Inc. (OTCBB:CLRI) maintaining its rating at Speculative Buy and a $3.00 price target. The...
LOS ANGELES--(BUSINESS WIRE)--Aug. 7, 2006-- Five Leading Medical Institutions Perform Surgeries throughout Country in First Month of Sales Clearant, Inc. (OTCBB:CLRI) today announced...
#20: CLRI News Dutton Associates Announces Investment Opinion: Clearant Update Coverage With Quarterly Preview and Comments On Expanded Direct Sales Product Portfolio By Dutton Associates
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Aug. 3, 2006--Dutton Associates updates its coverage of Clearant Inc. (OTCBB:CLRI) with two research notes reviewing expected quarterly results, and...
LOS ANGELES--(BUSINESS WIRE)--Aug. 3, 2006-- New Products Expand Product Opportunities to Markets Generating More Than $350 Million in Sales from $100 Million Previously Clearant, Inc....
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--July 27, 2006--Dutton Associates updates its coverage of Clearant Inc. (OTCBB:CLRI) maintaining a Speculative Buy rating and a $3.00 price target. The...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--July 12, 2006--Dutton Associates updates its coverage of Clearant Inc. (OTCBB:CLRI) for surgeons' positive response to its process, maintaining its rating...
#16: CLRI News Clearant Gains Support for Clearant Process(R) Sterile Implants at the American Orthopaedic Society for Sports Medicine Annual Conference; Medical Conference Generates Surgeons Interest in Converting to Clearant Process Sterile Implants
LOS ANGELES--(BUSINESS WIRE)--July 11, 2006--Clearant, Inc. (OTCBB:CLRI) today announced that it received a groundswell of interest from orthopedic surgeons considering using sterile allograft...
#15: CLRI News Clearant Sterile Bone Implants Used for First Time in Successful Spinal Surgery at UCLA; Company Achieves Significant Milestone in Direct Distribution Program
LOS ANGELES--(BUSINESS WIRE)--July 7, 2006--Clearant, Inc. (OTCBB:CLRI) today announced that two Clearant Sterile Implants were used in a successful two-level cervical fusion surgery done last week...
#14: CLRI News Clearant Expands Adoption of Clearant Process with Surgeon Community Programs at the American Orthopaedic Society for Sports Medicine Conference
LOS ANGELES--(BUSINESS WIRE)--June 26, 2006-- Leading Orthopaedic Surgeons Join Clearant in Educational Symposium Addressing Safety and Sterilization of Allograft Implants, Effectiveness of...
#13: CLRI News Clearant Achieves Another Key Milestone in Direct Distribution of Tissue Implants to Surgeons, Hospitals and Clinics: Company Announces the Launch of Clearant Sterile Implants Through Direct Sales Force
LOS ANGELES--(BUSINESS WIRE)--June 21, 2006-- Clearant Executes Direct Distribution Strategy to Meet Rising Demand for Sterile Tissue Transplant Materials Clearant, Inc. (OTCBB:CLRI)...
#12: CLRI News Clearant Announces Presentation of Clinical Data on the CLEARANT PROCESS(R) by Dr. Fred Cushner at Annual Meeting of the European Association of Tissue Banks
LOS ANGELES--(BUSINESS WIRE)--Dec. 12, 2005-- Findings Demonstrate High Doses of Gamma Irradiation Do Not Compromise the Structural or Biological Integrity of Human Soft Allograft Tissues...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dec. 9, 2005--Dutton Associates updates its coverage of Clearant, Inc. (OTCBB:CLRI) maintaining its rating at Speculative Buy and a $5.50 price target. The...
#10: CLRI News Osprey Biomedical Chooses Clearant's Sterilization Process for Its Bone Allograft Implants Sterilization Needs - 7th Tissue Agreement for North America
LOS ANGELES--(BUSINESS WIRE)--Dec. 6, 2005--Clearant, Inc. (OTCBB:CLRI), the developer and marketer of the patent-protected CLEARANT PROCESS(R) for pathogen inactivation of biologics, announced...
LOS ANGELES--(BUSINESS WIRE)--Nov. 10, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent-protected CLEARANT PROCESS(R) for pathogen inactivation, today announced that it has completed...
